Compounded semaglutide is a version of the semaglutide molecule mixed by a compounding pharmacy rather than manufactured and approved as a finished product. It is not FDA-approved or FDA-reviewed, while Wegovy, Ozempic, and Rybelsus are. That approval gap is the single most important distinction to understand before any conversation with a prescriber.
Key takeaways
- Compounded semaglutide is not FDA-approved or FDA-reviewed; the FDA-approved semaglutide products are Wegovy, Ozempic, and Rybelsus.
- Much compounding expanded during a shortage era, and what is permissible can change when the FDA declares a shortage resolved.
- The FDA has published concerns about dosing errors, unapproved salt forms, quality variability, and online sellers.
- Verifying a state-licensed pharmacy and preparing questions for your prescriber matter more than any single online claim.
Short Answer: What Is Compounded Semaglutide and How Does It Differ?
Compounded medicines are prepared by pharmacies that combine, mix, or alter ingredients to make a product for a specific patient's needs. Compounded semaglutide refers to preparations containing the semaglutide molecule made this way, rather than a finished drug that a manufacturer has taken through the FDA approval process.
The practical difference is oversight. FDA-approved products such as Wegovy, Ozempic, and Rybelsus have been reviewed for safety, effectiveness, manufacturing quality, labeling, and — for the injectable products — a specific delivery device. Compounded versions have not gone through that review. That does not make every compounded preparation identical or automatically unsafe, but it does mean the assurances that come with approval are absent, which is why the FDA frames unapproved GLP-1 products as carrying added risk.
This article is strictly educational. It does not recommend a product, a pharmacy, or a price, and it is not a substitute for guidance from your prescriber or pharmacist. Do not start, stop, or change any medicine based on what you read online.
Is Compounded Semaglutide FDA Approved?
No. There are no FDA-approved compounded semaglutide products. Approval applies to specific finished products from a manufacturer, and the semaglutide products that hold FDA approval are Wegovy (for chronic weight management) and Ozempic and Rybelsus (for type 2 diabetes). A compounded preparation, by definition, is not one of those approved products.
This distinction is easy to blur because the active molecule can carry the same name. But "contains semaglutide" is not the same as "is an FDA-approved semaglutide product." The FDA notes that it does not review compounded drugs for safety, effectiveness, or quality before they reach patients. That review gap is the core of the approval question, and it is the reason the phrase "FDA approved" cannot honestly be applied to compounded semaglutide.
Why Compounding Expanded — And What Changes When a Shortage Is Resolved
Federal rules allow certain compounding when an FDA-approved drug is in shortage, because compounded preparations can help patients when the approved product is temporarily unavailable. During periods when semaglutide products were listed on the FDA shortage list, that context drove a surge in compounded availability.
When the FDA determines a shortage is resolved and removes a product from the shortage list, the conditions that permitted some of that compounding change. The FDA has explained how compounding of drugs on its shortage list is affected once a shortage ends. The takeaway for patients is that the availability landscape is not static: a preparation that was widely offered during a shortage may be handled very differently afterward. Because these determinations and timelines shift, a prescriber and pharmacist are the right people to explain what currently applies to your situation.
The FDA's Published Concerns About Compounded Semaglutide
The FDA has described several specific concerns with unapproved and compounded semaglutide. These are worth understanding plainly, not as alarm, but as the reasons approval and oversight exist in the first place.
| FDA-described concern | Why it matters |
|---|---|
| Dosing errors | Products supplied in vials that require drawing up a dose in units can lead to measurement mistakes, and the FDA has received reports of adverse events linked to such errors. Approved products use a specific reviewed delivery format. |
| Unapproved salt forms | Some compounded products have used salt forms such as semaglutide sodium or semaglutide acetate, which are different from the active ingredient in the approved products and have not been shown to be safe or effective. |
| Quality variability | Because compounded preparations are not reviewed before reaching patients, purity, strength, and sterility can vary between pharmacies and batches. |
| Online and unregulated sellers | Products sold through unverified online sellers may not come from a licensed pharmacy at all, adding counterfeiting and contamination risks. |
The FDA has specifically warned about dosing errors and adverse event reports involving compounded semaglutide, and it has flagged the use of unapproved salt forms as a distinct issue. None of this is a diagnosis of any one product; it is a description of category-level risks that approval and licensed dispensing are designed to reduce. For a broader view of GLP-1 safety topics that apply regardless of source, our overview of long-term GLP-1 side effects separates common effects from serious labeled warnings.
Compounded Semaglutide vs Wegovy: A Side-by-Side Comparison
The most useful way to weigh "compounded semaglutide vs Wegovy" is not by molecule alone but by the layers of oversight around each. The comparison below is educational and general; it is not a recommendation, and the specifics for any individual belong with a prescriber.
| Feature | FDA-approved Wegovy | Compounded semaglutide |
|---|---|---|
| FDA approval | Yes — reviewed for safety, effectiveness, and quality | No — not FDA-approved or FDA-reviewed |
| Pre-market oversight | Manufacturing and quality reviewed before sale | Not reviewed before reaching patients |
| Delivery and labeling | Specific reviewed device and standardized labeling | Format varies; may require drawing doses in units from vials |
| Active ingredient | The specific semaglutide form in the approved product | May include unapproved salt forms in some products |
| Source | Licensed distribution of a finished manufactured product | Prepared by a compounding pharmacy; quality can vary by source |
The same logic applies to "compounded semaglutide vs Ozempic": Ozempic is an FDA-approved semaglutide product for type 2 diabetes, so the approval, oversight, device, and source columns above apply in the same way. If your interest is specifically the diabetes side of these medicines, our explainer on whether Wegovy is used for diabetes clarifies which semaglutide products are approved for which use. What this table cannot answer is which option is appropriate for a given person — that is a clinical judgment.
Is Compounded Semaglutide Safe? An Honest Framing
"Is compounded semaglutide safe?" is a fair question, and the honest answer is that safety depends heavily on factors the FDA review process is designed to standardize — factors that are not guaranteed with compounded products. The absence of pre-market review means purity, strength, sterility, and the exact active ingredient can vary, and the FDA has documented adverse events tied to dosing errors and to unapproved salt forms.
That is different from saying every compounded preparation from a state-licensed pharmacy is dangerous. Legitimate compounding has a long-standing, regulated role in medicine. But the safeguards that come with an approved product are simply not present, so the risk profile is not equivalent, and it cannot be assumed away by the molecule's name. Side effects common to the semaglutide class can occur regardless of source; our guide on how long semaglutide diarrhea tends to last covers one of the more frequently reported effects and when to contact a clinician.
The American Diabetes Association describes GLP-1 receptor agonists as a class of prescription medicines used under clinical supervision, which underscores that any semaglutide product — approved or compounded — belongs in a care relationship rather than a self-directed purchase. Questions about stopping are also common; our piece on what happens when you stop taking a GLP-1 walks through that in plain language.
How to Verify a State-Licensed Pharmacy
If a prescriber and patient decide a compounded preparation is being considered, verifying that it comes from a legitimate, state-licensed pharmacy is a concrete safety step. This is about the source, not an endorsement of any product.
- Check the state board of pharmacy — Every pharmacy should be licensed by the board in its state. State boards maintain lookup tools to confirm a license is current and in good standing.
- Use FDA BeSafeRx — The FDA's BeSafeRx resource helps patients spot signs of an unsafe online pharmacy and identify ones that operate legitimately.
- Watch for red flags — Sites that sell without a prescription, offer prices that seem implausible, lack a verifiable physical pharmacy, or ship from unclear locations are warning signs.
- Ask your prescriber and pharmacist directly — They can help confirm whether a source is legitimate and whether a given preparation fits your plan.
Guidance for handling any GLP-1 preparation once you have it — including sterility, temperature, and travel considerations — is covered in our companion piece on GLP-1 storage and travel, and the same source-verification discipline applies to the tirzepatide side of these medicines, which our compounded tirzepatide explainer addresses with the same FDA-first framing.
A Question Checklist for Your Prescriber
You do not need to be a pharmacology expert to have a productive, safety-minded conversation. A short written list keeps the discussion focused on your situation rather than on marketing claims. This is a framework for organizing a conversation, not medical advice.
- Is an FDA-approved semaglutide product appropriate and available for my situation?
- If a compounded preparation is being discussed, what is the source, and is it a state-licensed pharmacy?
- What active ingredient and salt form does the preparation contain?
- How is the dose measured and delivered, and how do I avoid a measurement error?
- What side effects should I watch for, and which ones warrant a same-day call or urgent care?
- How will we monitor and follow up, and what is the plan if something changes?
The through-line is simple: FDA-approved products carry oversight that compounded ones do not, source verification is a concrete safety step, and your prescriber and pharmacist are the constant partners in any decision. That combination lets you weigh options calmly without turning a complex topic into either fear or false reassurance.
Frequently Asked Questions
Is compounded semaglutide FDA approved?
No. There are no FDA-approved compounded semaglutide products. FDA approval applies to specific finished products from a manufacturer, and the semaglutide products that hold approval are Wegovy for chronic weight management and Ozempic and Rybelsus for type 2 diabetes. Compounded preparations are not reviewed by the FDA for safety, effectiveness, or quality before they reach patients, so the phrase FDA approved cannot honestly be applied to them. Your prescriber and pharmacist can explain what applies to your situation.
What is the difference between compounded semaglutide and Wegovy?
Wegovy is an FDA-approved finished product that has been reviewed for safety, effectiveness, manufacturing quality, labeling, and a specific delivery device. Compounded semaglutide is prepared by a compounding pharmacy and has not gone through that review, so oversight of purity, strength, dosing format, and the exact active ingredient is not guaranteed in the same way. The active molecule may share a name, but that is not the same as being an approved product. Any comparison for an individual belongs with a prescriber.
Is compounded semaglutide safe?
Safety depends heavily on factors the FDA review process is designed to standardize, and those factors are not guaranteed with compounded products. Because compounded preparations are not reviewed before reaching patients, purity, strength, sterility, and the exact active ingredient can vary, and the FDA has documented adverse events tied to dosing errors and to unapproved salt forms. This does not mean every preparation from a state-licensed pharmacy is dangerous, but the safeguards that come with an approved product are not present, so the risk profile is not equivalent.
How is compounded semaglutide different from Ozempic?
Ozempic is an FDA-approved semaglutide product for type 2 diabetes, so the same distinctions that apply to Wegovy apply here. Ozempic has been reviewed for safety, effectiveness, and quality, uses a specific reviewed delivery format, and comes from licensed distribution of a finished manufactured product. Compounded semaglutide has not been through that review, may be supplied in a format that requires drawing doses from vials, and can vary in quality by source. Which option is appropriate is a clinical decision for your prescriber.
Why did compounded semaglutide become so widely available?
Federal rules allow certain compounding when an FDA-approved drug is in shortage, because compounded preparations can help patients when the approved product is temporarily unavailable. During periods when semaglutide products were listed on the FDA shortage list, that context drove a surge in compounded availability. When the FDA determines a shortage is resolved and removes a product from the list, the conditions that permitted some of that compounding change, so the availability landscape is not static. A prescriber and pharmacist can explain what currently applies.
What are unapproved salt forms of semaglutide?
Some compounded products have used salt forms such as semaglutide sodium or semaglutide acetate, which are chemically different from the active ingredient in the FDA-approved products. The FDA has flagged these salt forms as a distinct concern because they have not been shown to be safe or effective, and they are not the same substance that was studied and approved. If a compounded preparation is being discussed, asking exactly what active ingredient and salt form it contains is a reasonable and important question for your prescriber and pharmacist.
How can I tell if an online pharmacy selling semaglutide is legitimate?
Start by confirming the pharmacy is licensed by the board of pharmacy in its state, since state boards maintain lookup tools to verify a license is current and in good standing. The FDA BeSafeRx resource can help you spot signs of an unsafe online pharmacy and identify ones that operate legitimately. Warning signs include selling without a prescription, prices that seem implausible, no verifiable physical pharmacy, and unclear shipping origins. Your prescriber and pharmacist can also help confirm whether a source is legitimate.
Should I switch from compounded semaglutide to an FDA-approved product?
That is a decision to make with your prescriber, not on your own or based on anything you read online. Whether an FDA-approved product is appropriate and available, how any transition should be handled, and what monitoring makes sense all depend on your medical history and your full plan. Do not start, stop, or change a medicine independently, because abrupt changes can affect blood glucose management and other parts of your care. Bringing a written list of questions helps make that conversation productive.
References
- FDA: Compounding and the FDA — Questions and Answers
- FDA: Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
- FDA: Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
- FDA: BeSafeRx — Your Source for Online Pharmacy Information
- American Diabetes Association: GLP-1 Receptor Agonists
Next Steps
Understanding compounded semaglutide comes down to a few durable facts: it is not FDA-approved or FDA-reviewed, the FDA-approved semaglutide products are Wegovy, Ozempic, and Rybelsus, and the FDA has published specific concerns about dosing, salt forms, quality, and online sellers. Verify any pharmacy through its state board and FDA BeSafeRx, and bring a written list of questions so the decision stays with your prescriber.
If you're ready to build the daily habits that support steadier blood sugar alongside any prescribed treatment, the Done With Diabetes™ program, a type 2 diabetes protocol, offers practical guidance on nutrition, movement, sleep, and daily routines. Get started with Vynleads to take the next step.